SS

Subbiah Shivraj Sundar Ganeeth

Active Director Director DIN 11246027
DIN 11246027 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Subbiah Shivraj Sundar Ganeeth

Data last updated:

Subbiah Shivraj Sundar Ganeeth is a Director at Sgm Sports And Lifesciences Private Limited (since 2025). The company operates in Pharma.

DIN 11246027
Primary Designation Director
Industry Pharma
First Appointment 18 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Aug 20252025Active

Directorship timeline

Open interactive timeline →
Sgm Sports And Lifesciences Private Limited
Premium access

Shareholding and investment profile for Subbiah Shivraj Sundar Ganeeth

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subbiah Shivraj Sundar Ganeeth

Subbiah Shivraj Sundar Ganeeth currently holds 1 directorship: Sgm Sports And Lifesciences Private Limited (Director, since 18 Aug 2025).

Subbiah Shivraj Sundar Ganeeth was first appointed on 18 Aug 2025 as Director at Sgm Sports And Lifesciences Private Limited.

The current boards of Subbiah Shivraj Sundar Ganeeth's companies include Badri Subha Parvathy (Sgm Sports And Lifesciences Private Limited), Mohammed Ibrahim Mohammed Ismail (Sgm Sports And Lifesciences Private Limited), Shivnath Badri (Sgm Sports And Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available